MarketResearch.biz delivers in-depth insights on the global cell harvesting market in its upcoming report titled, “Global Cell Harvesting Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2026”. The global cell harvesting market is estimated to register a CAGR of XX.X% in terms of value during forecast period 2017–2026. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2026. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global cell harvesting market report has been segmented on the basis of type, application, end-user, and region.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analyzed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
Cell harvesting is an advance technique, wherein stem cells are collected and are used for transplant, regeneration, or repair of damaged or unhealthy organs with healthy ones. Stem cells can be harvested from bone marrow or from the cord blood in the umbilical cord.
Increasing demand for stem cell based therapies and increasing prevalence of chronic conditions are major factors driving growth of the global cell harvesting market. In addition, rising investments for research and development (R&D) of stem cell based surgeries is another factor fueling growth of the global market. Increasing stem cell banking is another factor driving growth of the global market. Moreover, increasing demand for regenerative medicine is another factor expected to further propel growth of the global market to a significant extent during the forecast period.
High cost of stem-cell treatment is a major factor hampering growth of the global cell harvesting market. In addition, embryonic stem cells may have high rejection rate and may cause several health problems in near future. This is another factor hampering growth of the global market to a certain extent. Technological advancements towards development of low cost harvesting process is expected to create lucrative opportunities for major players in the global market over the forecast period.
The market in North America accounts for highest revenue share in the global cell harvesting market and is expected to maintain its dominance over the forecast period. Increasing adoption of cell harvesting technique for treatment of cancer and skin related disorder, presence of advanced healthcare infrastructure, and rising investment for cell-based research are major factors driving growth of the North America cell harvesting market. The Europe cell harvesting market is expected to witness significant growth and is expected to register a CAGR of X.X% over the forecast period. The Asia Pacific cell harvesting market is expected to witness highest growth and is projected to register a CAGR of XX.X% over the next 10 years. This growth can be attributed to rapid development in healthcare sector in countries in this region.
Global cell harvesting market segmentation:
Segmentation on the basis of type:
- Manual Cell Harvesters
- Automated Cell Harvesters
Segmentation on the basis of application:
- Biopharmaceutical Application
- Stem Cell Research
Segmentation on the basis of end user:
- Biotechnology & Biopharmaceutical Companies
- Research Institutes
Segmentation on the basis of region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2027 Revenue in US$
- Perkinelmer Inc.
- ADS Biotec Inc.
- General Electric
- COX Scientific Ltd.
- Sartorius AG
- Terumo BCT Inc.
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!